Sunshield Chemicals Ltd
₹ 773
-1.87%
19 Apr
- close price
About
Sunshield Chemicals Ltd is engaged in the manufacture and sale of Speciality Chemicals in the domestic and international markets. [1]
Key Points
- Market Cap ₹ 568 Cr.
- Current Price ₹ 773
- High / Low ₹ 1,048 / 521
- Stock P/E 35.1
- Book Value ₹ 98.4
- Dividend Yield 0.26 %
- ROCE 19.3 %
- ROE 22.8 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 62.6% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 36.1%
Cons
- Stock is trading at 7.86 times its book value
- The company has delivered a poor sales growth of 5.95% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
94 | 105 | 134 | 119 | 150 | 166 | 183 | 190 | 181 | 199 | 244 | 245 | 264 | |
87 | 97 | 122 | 117 | 140 | 157 | 168 | 173 | 164 | 169 | 213 | 214 | 229 | |
Operating Profit | 8 | 8 | 11 | 2 | 10 | 9 | 16 | 16 | 17 | 30 | 31 | 31 | 36 |
OPM % | 8% | 8% | 8% | 2% | 7% | 5% | 8% | 9% | 9% | 15% | 13% | 13% | 13% |
1 | 0 | -0 | 1 | 3 | -2 | 2 | 1 | 0 | 0 | 19 | 2 | 2 | |
Interest | 6 | 5 | 4 | 3 | 11 | 9 | 10 | 11 | 10 | 7 | 5 | 7 | 8 |
Depreciation | 2 | 2 | 2 | 3 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 |
Profit before tax | 1 | 1 | 5 | -4 | -3 | -8 | 2 | 0 | 1 | 17 | 39 | 19 | 23 |
Tax % | -17% | 18% | 107% | 19% | 75% | 16% | 20% | 0% | 46% | 15% | 30% | 28% | |
1 | 1 | -0 | -3 | -1 | -7 | 1 | 0 | 1 | 14 | 27 | 14 | 16 | |
EPS in Rs | 1.32 | 1.14 | -0.54 | -4.32 | -1.16 | -9.07 | 1.63 | 0.30 | 0.87 | 19.28 | 37.37 | 18.58 | 22.04 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 5% | 11% |
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 6% |
3 Years: | 11% |
TTM: | 8% |
Compounded Profit Growth | |
---|---|
10 Years: | 32% |
5 Years: | 63% |
3 Years: | 125% |
TTM: | 24% |
Stock Price CAGR | |
---|---|
10 Years: | 15% |
5 Years: | 39% |
3 Years: | 46% |
1 Year: | 27% |
Return on Equity | |
---|---|
10 Years: | 17% |
5 Years: | 33% |
3 Years: | 36% |
Last Year: | 23% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
Reserves | 13 | 14 | 14 | 10 | 9 | 2 | 4 | 4 | 4 | 19 | 46 | 59 | 65 |
42 | 44 | 56 | 75 | 101 | 100 | 110 | 106 | 109 | 88 | 79 | 77 | 79 | |
15 | 16 | 23 | 39 | 33 | 31 | 36 | 31 | 26 | 24 | 41 | 34 | 44 | |
Total Liabilities | 78 | 81 | 100 | 131 | 151 | 141 | 157 | 148 | 147 | 138 | 173 | 177 | 196 |
36 | 36 | 34 | 31 | 79 | 74 | 71 | 69 | 71 | 66 | 71 | 79 | 76 | |
CWIP | 0 | 0 | 3 | 48 | 2 | 3 | 3 | 3 | 0 | 1 | 7 | 1 | 14 |
Investments | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
37 | 41 | 63 | 53 | 70 | 64 | 83 | 76 | 76 | 71 | 95 | 97 | 105 | |
Total Assets | 78 | 81 | 100 | 131 | 151 | 141 | 157 | 148 | 147 | 138 | 173 | 177 | 196 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
9 | 15 | -7 | 13 | 1 | 12 | 2 | 15 | 19 | 35 | 33 | 14 | |
-7 | -1 | -3 | -31 | -17 | -3 | -4 | -2 | -7 | -4 | -17 | -9 | |
-2 | -14 | 12 | 15 | 18 | -8 | 3 | -30 | -24 | -7 | -9 | -11 | |
Net Cash Flow | 0 | -0 | 2 | -3 | 2 | 1 | 1 | -18 | -11 | 23 | 7 | -5 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 74 | 76 | 90 | 36 | 62 | 60 | 59 | 51 | 57 | 53 | 62 | 60 |
Inventory Days | 56 | 57 | 52 | 86 | 100 | 76 | 91 | 81 | 92 | 79 | 66 | 83 |
Days Payable | 69 | 66 | 55 | 70 | 91 | 71 | 70 | 60 | 72 | 63 | 74 | 54 |
Cash Conversion Cycle | 61 | 67 | 87 | 52 | 72 | 65 | 80 | 72 | 77 | 69 | 53 | 89 |
Working Capital Days | 56 | 28 | 103 | 30 | 80 | 34 | 84 | 38 | 93 | 72 | 73 | 96 |
ROCE % | 11% | 10% | 13% | -1% | 7% | 3% | 10% | 11% | 10% | 20% | 21% | 19% |
Documents
Announcements
- Compliance - Regulation 40(10) Of SEBI (Listing Obligations And Disclosures Requirements) Regulation 2015 14h
- Compliance - Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosures Requirements) Regulation 2015 For Year Ended 31 March 2024 4 Apr
- Closure of Trading Window 27 Mar
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
11 Feb - Copy of newspaper advertisement (Result Publication) published Newspaper.
- Results - 31.12.2023 9 Feb
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Product
The product portfolio of the co includes Amines, Antioxidants, and Stabilizers, Barium and Strontium Derivatives, Calcium and Magnesium Derivatives, Composites, Flavors and Fragrances, Fluorine Derivatives, Lithium Derivatives, etc. [1]